Dataset Information


Psychometric properties of the Norwegian version of the Patient Health Questionnaire-9 (PHQ-9) in a large female sample of adults with and without eating disorders.



Internationally, the Patient Health Questionnaire-9 (PHQ-9) is commonly used to assess the frequency and severity of depressive symptoms. However, psychometric properties of the Norwegian version of the PHQ-9 have only been assessed in adolescents. We present normative data for women and an evaluation of the psychometric properties (internal consistency, convergent validity, and factor structure) of the Norwegian PHQ-9 among women with and without eating disorders (ED).


In this case-control study, a total of 793 females aged 18-78?years (mean 30.39; SD 9.83) completed an online self-report assessment. Measures included the ED100K and Eating Disorder Examination Questionnaire (EDE-Q) to assess ED psychopathology, and the Generalized Anxiety Disorder (GAD) scale and Difficulties in Emotion Regulation Scale Short Form (DERS-SF) to assess symptoms of anxiety and emotion regulation deficits. Participants were categorized into three groups, i.e., previous ED (19.7%, n?=?148), current ED (36.3%, n?=?272), and no history of ED (44.0%, n?=?330), based on self-reported scores on the ED 100?K and the EDE-Q.


Mean PHQ-9 total score for those with a previous history of ED was 10.67 (SD 6.33), for those with a current ED 16.61 (SD 5.84), and for those with no lifetime history of ED 6.83 (SD 5.58). Excellent internal consistency was demonstrated by Cronbach's alpha's for individuals with a previous ED (.88), for individuals with a current ED (.86), and for individuals with no history of ED (.88). Acceptable convergent validity was indicated based on significant correlations between the PHQ-9 and GAD-7 and DERS-SF. Confirmatory Factor Analyses revealed a mediocre fit for a one-factor structure of the PHQ-9, regardless of diagnostic status.


The psychometric properties of the Norwegian version of the PHQ-9 are acceptable across females with and without ED, and the PHQ-9 can be recommended for use in clinical ED settings and for people without mental disorders.


PROVIDER: S-EPMC7786911 | BioStudies | 2021-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4854480 | BioStudies
1000-01-01 | S-EPMC5928750 | BioStudies
2019-01-01 | S-EPMC6817603 | BioStudies
2020-01-01 | S-EPMC7193412 | BioStudies
2017-01-01 | S-EPMC5734731 | BioStudies
2021-01-01 | S-EPMC7921165 | BioStudies
2019-01-01 | S-EPMC6813743 | BioStudies
2020-01-01 | S-EPMC7304148 | BioStudies
2016-01-01 | S-EPMC4820124 | BioStudies
2018-01-01 | S-EPMC6746095 | BioStudies